SOPHION BIOSCIENCE A/S: Financial statements 2022
CVR: 10021065
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 117,686,000 and a net result of DKK 44,369,000 compared with DKK 36,324,000 the year before. That is an increase of 19.7% compared with the year before. Equity in the 2022 report amounted to DKK 188,146,000. The solvency ratio was 84.5%. The company had 48 employees in the financial year.
- Gross Profit
- DKK 117,686,000
- Profit/Loss
- DKK 44,369,000
- Equity
- DKK 188,146,000
- Total Assets
- DKK 222,631,000
- Employees
- 48
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 117.7 mio. | 44.4 mio. | 188.1 mio. | 48 |
| 2021 | - | 98.3 mio. | 36.3 mio. | 143.8 mio. | 41 |
| 2020 | - | 77.5 mio. | 25.2 mio. | 106.5 mio. | 35 |
| 2019 | - | 78.4 mio. | 22.6 mio. | 101.1 mio. | 38 |
| 2018 | - | 70.8 mio. | 40.3 mio. | 98.3 mio. | 38 |
Official annual report
Keep an eye on SOPHION BIOSCIENCE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SOPHION BIOSCIENCE A/S has published its annual report for 2021. Gross profit came to DKK 98,346,000, and the net result was DKK 36,324,000.
About SOPHION BIOSCIENCE A/S
SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named IONS A/S and KR 228 A/S. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by Sapphire Bioscience Holding ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity in the 2025 report amounted to DKK 178,418,000.